Immunomedics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:N/A
Lead Investor(s):Goldman, Sachs & Co.

Estimated Revenue & Financials

  • Immunomedics's estimated annual revenue is currently $34.6M per year.(?)
  • Immunomedics received $125.0M in venture funding in May 2017.
  • Immunomedics's estimated revenue per employee is $148,987

Employee Data

  • Immunomedics has 232 Employees.(?)
  • Immunomedics grew their employee count by -30% last year.
  • Immunomedics currently has 63 job openings.

Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer and other serious diseases. Immunomedics corporate objective is to become a fully-integrated biopharmaceutical company and a leader in the field of antibody-drug conjugates.

keywords:Biotechnology,Cleantech,Healthcare,Medical Diagnostics,Pharmaceuticals,Wind Power